Functional status of mechanically ventilated COVID-19 survivors at ICU and hospital discharge.
COVID-19 sequela
Coronavirus disease 2019
Functional outcome
Invasive mechanical ventilation
Late effects of COVID-19 infection
Journal
Journal of intensive care
ISSN: 2052-0492
Titre abrégé: J Intensive Care
Pays: England
ID NLM: 101627304
Informations de publication
Date de publication:
31 Mar 2021
31 Mar 2021
Historique:
received:
08
12
2020
accepted:
02
03
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
2
4
2021
Statut:
epublish
Résumé
A significant number of COVID-19 patients have been treated using invasive mechanical ventilation (IMV). The ability to evaluate functional status of COVID-19 survivors early on at ICU and hospital discharge may enable identification of patients who may need medical and rehabilitation interventions. The modified "Mental Status", ICU Mobility, and Barthel Index scores at ICU and hospital discharge were tabulated for 118 COVID-19 survivors treated with invasive mechanical ventilation (IMV). These functional scores were compared with pre-admission functional status, discharge durable medical equipment, discharge medical follow-up recommendation, duration on IMV, duration post-IMV, demographics, comorbidities, laboratory tests, and vital signs at ICU and hospital discharge. The majority of COVID-19 IMV patients were not functionally independent at hospital discharge (22% discharged with cane or rolling walker, 49% discharged with durable medical equipment, and 14% admitted to a rehabilitation facility), although 94% of these patients were functionally independent prior to COVID-19 illness. Half of the patients were discharged with supplemental oxygen equipment. The most prevalent medical follow-up recommendations were cardiology, vascular medicine, pulmonology, endocrinology, and neurology with many patients receiving multiple medical follow-up recommendations. Functional status improved from ICU discharge to hospital discharge (p < 0.001). Worse functional status at hospital discharge was associated with longer IMV duration, older age, male sex, higher number of comorbidities, and the presence of pre-existing comorbidities including hypertension, diabetes, chronic obstructive pulmonary disease, and immunosuppression (p < 0.05, ANOVA). The majority of IMV COVID-19 survivors were not functionally independent at discharge and required significant follow-up medical care. The COVID-19 circumstance has placed constraints on access to in-hospital rehabilitation. These findings underscore the need for prospective studies to ascertain the short- and long-term sequela in COVID-19 survivors.
Sections du résumé
BACKGROUND
BACKGROUND
A significant number of COVID-19 patients have been treated using invasive mechanical ventilation (IMV). The ability to evaluate functional status of COVID-19 survivors early on at ICU and hospital discharge may enable identification of patients who may need medical and rehabilitation interventions.
METHODS
METHODS
The modified "Mental Status", ICU Mobility, and Barthel Index scores at ICU and hospital discharge were tabulated for 118 COVID-19 survivors treated with invasive mechanical ventilation (IMV). These functional scores were compared with pre-admission functional status, discharge durable medical equipment, discharge medical follow-up recommendation, duration on IMV, duration post-IMV, demographics, comorbidities, laboratory tests, and vital signs at ICU and hospital discharge.
RESULTS
RESULTS
The majority of COVID-19 IMV patients were not functionally independent at hospital discharge (22% discharged with cane or rolling walker, 49% discharged with durable medical equipment, and 14% admitted to a rehabilitation facility), although 94% of these patients were functionally independent prior to COVID-19 illness. Half of the patients were discharged with supplemental oxygen equipment. The most prevalent medical follow-up recommendations were cardiology, vascular medicine, pulmonology, endocrinology, and neurology with many patients receiving multiple medical follow-up recommendations. Functional status improved from ICU discharge to hospital discharge (p < 0.001). Worse functional status at hospital discharge was associated with longer IMV duration, older age, male sex, higher number of comorbidities, and the presence of pre-existing comorbidities including hypertension, diabetes, chronic obstructive pulmonary disease, and immunosuppression (p < 0.05, ANOVA).
CONCLUSIONS
CONCLUSIONS
The majority of IMV COVID-19 survivors were not functionally independent at discharge and required significant follow-up medical care. The COVID-19 circumstance has placed constraints on access to in-hospital rehabilitation. These findings underscore the need for prospective studies to ascertain the short- and long-term sequela in COVID-19 survivors.
Identifiants
pubmed: 33789772
doi: 10.1186/s40560-021-00542-y
pii: 10.1186/s40560-021-00542-y
pmc: PMC8011060
doi:
Types de publication
Journal Article
Langues
eng
Pagination
31Références
Chest. 2016 Nov;150(5):1129-1140
pubmed: 27063347
J Infect Dis. 2020 Sep 14;222(8):1256-1264
pubmed: 32702098
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
PeerJ. 2020 Nov 06;8:e10337
pubmed: 33194455
J Am Coll Emerg Physicians Open. 2020 Aug 25;1(6):1364-1373
pubmed: 32838390
Chest. 2016 Oct;150(4):966-971
pubmed: 27312737
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Bioeth Inq. 2020 Dec;17(4):471-472
pubmed: 32840853
Clin Infect Dis. 2020 Nov 19;71(16):2073-2078
pubmed: 32358960
Chest. 2007 May;131(5):1541-9
pubmed: 17494803
Cleve Clin J Med. 2020 Aug 5;:
pubmed: 32759175
J Med Virol. 2020 Sep;92(9):1449-1459
pubmed: 32242947
Lancet. 2009 May 30;373(9678):1874-82
pubmed: 19446324
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JMIR Public Health Surveill. 2020 May 8;6(2):e19462
pubmed: 32369030
Lancet. 2020 Apr 25;395(10233):1382-1393
pubmed: 32277878
PLoS One. 2020 Jul 30;15(7):e0236618
pubmed: 32730358
Eur Respir J. 2020 Oct 15;56(4):
pubmed: 32764112
Crit Care. 2020 Apr 28;24(1):176
pubmed: 32345343
Phys Ther. 2020 Jul 19;100(7):1062-1073
pubmed: 32280993
Int J Med Sci. 2021 Feb 18;18(8):1739-1745
pubmed: 33746590
Stroke. 2013 Feb;44(2):462-8
pubmed: 23299497
Ann Palliat Med. 2020 Mar;9(2):175-181
pubmed: 32156142
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1338-44
pubmed: 12421743
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
JAMA. 2020 Nov 3;324(17):1723-1724
pubmed: 33031513
Thromb Res. 2020 Oct;194:101-115
pubmed: 32788101
Heart Lung. 2014 Jan-Feb;43(1):19-24
pubmed: 24373338
Am J Cardiovasc Drugs. 2020 Aug;20(4):311-324
pubmed: 32578167
Crit Care. 2020 Jul 2;24(1):389
pubmed: 32616077